![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Intas Pharmaceuticals Limited Ahmedabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Doxorubicin Hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2012-367 - Rev 02
This Chemical Type CEP, issued on March 20, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 714 associated with this CEP further emphasizes